- Home
- BTBD vs BMRA Comparison
BTBD vs BMRA Comparison
Compare BTBD & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBD
- BMRA
- Stock Information
- Founded
- BTBD 1987
- BMRA 1971
- Country
- BTBD United States
- BMRA United States
- Employees
- BTBD N/A
- BMRA N/A
- Industry
- BTBD Restaurants
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BTBD Consumer Discretionary
- BMRA Health Care
- Exchange
- BTBD Nasdaq
- BMRA Nasdaq
- Market Cap
- BTBD 8.3M
- BMRA 8.1M
- IPO Year
- BTBD 2021
- BMRA N/A
- Fundamental
- Price
- BTBD $1.27
- BMRA $3.34
- Analyst Decision
- BTBD
- BMRA
- Analyst Count
- BTBD 0
- BMRA 0
- Target Price
- BTBD N/A
- BMRA N/A
- AVG Volume (30 Days)
- BTBD 3.1K
- BMRA 46.7K
- Earning Date
- BTBD 08-12-2025
- BMRA 08-27-2025
- Dividend Yield
- BTBD N/A
- BMRA N/A
- EPS Growth
- BTBD N/A
- BMRA N/A
- EPS
- BTBD N/A
- BMRA N/A
- Revenue
- BTBD $14,864,398.00
- BMRA $5,678,000.00
- Revenue This Year
- BTBD N/A
- BMRA N/A
- Revenue Next Year
- BTBD N/A
- BMRA N/A
- P/E Ratio
- BTBD N/A
- BMRA N/A
- Revenue Growth
- BTBD 4.71
- BMRA 5.01
- 52 Week Low
- BTBD $1.00
- BMRA $1.93
- 52 Week High
- BTBD $2.02
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- BTBD 43.34
- BMRA 49.88
- Support Level
- BTBD $1.32
- BMRA $3.25
- Resistance Level
- BTBD $1.36
- BMRA $3.66
- Average True Range (ATR)
- BTBD 0.03
- BMRA 0.18
- MACD
- BTBD -0.01
- BMRA 0.03
- Stochastic Oscillator
- BTBD 0.00
- BMRA 51.28
About BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.